Nuevolution A/S
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
4
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Compounds Active Towards Nuclear Receptors (US 11,685,727) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Mar 1, 2027The maintenance fee for Quasirandom structure and function guided synthesis methods (US 9,121,110) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
- 1 fee due Apr 10, 2027The maintenance fee for Compounds Active Towards Nuclear Receptors (US 11,780,843) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
Recent changes
- 1 term has ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,702,652 | Enzymatic encoding methods for efficient synthesis of large libraries In force · From the USPTO record | In force | From the USPTO record | |
| US 9,121,110 | Quasirandom structure and function guided synthesis methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,118,215 | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 10,730,906 | Multi-step synthesis of templated molecules In force · From the USPTO record | In force | From the USPTO record | |
| US 12,649,918 | Bi-Functional Complexes and Methods for Making and Using Such Complexes In force · High confidence | In force | High confidence | |
| US 9,574,189 | Enzymatic encoding methods for efficient synthesis of large libraries In force · From the USPTO record | In force | From the USPTO record | |
| US 11,225,655 | Bi-Functinal Complexes and Methods for Making and Using Such Complexes In force · High confidence | In force | High confidence | |
| US 10,752,640 | Compounds active towards bromodomains In force · From the USPTO record | In force | From the USPTO record | |
| US 10,683,293 | Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for the Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases In force · High confidence | In force | High confidence | |
| US 10,689,383 | Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for the Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases In force · High confidence | In force | High confidence |
Also on record, not counted in the 16: 3 lapsed for an unpaid fee · 20 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 10 no status recorded